Novo Nordisk A/S Canadian Depositary Receipt (NOV0)
Market Closed
3 Jun, 20:00
XFRA XFRA Primary €
2. 6800
-0.06
-2.19%
€
13.03B Market Cap
48.26 P/E Ratio
0.32% Div Yield
3,050 Volume
0 Eps
€ 2.74
Previous Close Want to track NOV0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S Canadian Depositary Receipt (NOV0) Statistics
Valuation metrics
Market Cap 13.03B
Enterprise value 18.48B
Trailing P/E (ttm) 0.8
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.04
Price/Book (mrq) 0.48
Enterprise Value/Revenue 0.42
Enterprise Value/EBITDA 0.79
Overview
Shares outstanding 4.44B
Float 3.19B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 151
Average volume (90 days) 158
Price summary
52-Week low 2.12
52-Week high 5.55
Beta 0.35
50-Day moving average 2.73
200-Day moving average 3.28
Dividends and splits
Forward annual dividend rate 0.16
Forward annual dividend yield 0.0552%
Trailing annual dividend rate 0.12
Trailing annual dividend yield 0.0406%
5-Year annual dividend yield -
Payout ratio 0.03
Dividend Date 7 Apr 2026
Ex-Dividend Date 30 Mar 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.37%
Operating margin 0.62%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.71%
Income Statement
Revenue (ttm) 43.86B
Revenue per share (ttm) 73.77
Quarterly revenue growth (yoy) 0.24%
Gross profit (ttm) 36.49B
EBITDA 181.54B
Net income to common (ttm) 16.32B
Diluted EPS (ttm) 3.67
Quarterly earnings growth (yoy) 0.67%
Balance Sheet
Total cash (mrq) 2.89B
Total cash per share (mrq) 4.87
Total debt (mrq) 19.59B
Total Debt/Equity (mrq) 72.09
Current ratio (mrq) 0.79%
Book value per share (mrq) 6.13
Cash Flow
Cash flow statement 15.85B
Levered free cash flow (LFCF) -1.61B
